CRT 2026

Panel Discussion

Moderator(s)

• 

  Spencer B. King, III, MD, MACC, MSCAI

  Professor of Medicine Emeritus
  Emory University
  Atlanta, Georgia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Charles A. Simonton, MD, FACC, FSCAI

  EVP Chief Medical Advisor
  Abiomed a Johnson + Johnson MedTech Company
  Charlotte, North Carolina, United States

  Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)

Panel Discussant(s)

• 

  Anthony DeMaria, MD

  Judy and Jack White Chair in Cardiology
  University of California, San Diego
  La Jolla, California, United States

  Disclosure(s): Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing)
• 

  Nabil Dib, MD, MSc, FACC

  Director Cardiovascular Research
  Mercy Gilbert Medical Center/Dignity Health
  Gilbert, Arizona, United States

  Disclosure(s): No financial relationships to disclose
• 

  Chip Hance, BS, MBA

  CEO
  Regatta Medical
  Bannockburn, Illinois, United States

  Disclosure information not submitted.
• TJ

  Tamara Syrek Jensen, JD

  Disclosure information not submitted.
• JL

  Joon Lee, MD

  Disclosure information not submitted.
• 

  Stanton J. Rowe, PhD

  CEO
  Nidus Biomedical
  Irvine, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ken Stein, MD

  Senior Vice President and Chief Medical Officer
  Boston Scientific
  St.Paul, Minnesota, United States

  Disclosure information not submitted.
• JS

  John B. Simpson, MD

  Disclosure information not submitted.
• 

  Bram Zuckerman, MD

  Director Office of CV Devices
  U.S. Food and Drug Administration
  Silver Spring, Maryland, United States

  Disclosure information not submitted.